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Background
As for other pathologies, the pathogenesis of venous
thrombo-embolism (VTE) is multifactorial. A compre-
hensive understanding of the pathogenesis of venous
thrombosis is essential for identifying patients at
increased risk as in elderly patients with congestive heart
failure (CHD) and with presence of chronic venous insuf-
ficiency (IVC). Eberhard Mammen postulated immobility
as the leading event in the CHD, because it reduced
blood flow as a result of decreased muscle contraction.
The subsequent “stasis of flow” led to accumulation of
blood within the intramuscular sinuses, especially of the
calf, triggering hypercoagulability due to local accumula-
tion of activated clotting factors and coagulation activa-
tion products and the simultaneous consumption of
blood coagulation inhibitors.
Materials and methods
We have analyzed, in the latest years, the results of a
comprehensive examination of 214 elderly (Group 1; aged
71+/12 years) hospitalized with CHD and 187 patients
(Group 2; aged 76+/-9 years) with CHD and venous
disorders (CVI) in class C2/3/C4 according to the CEAP
classification (detected by systematic compression ultra-
sound and hemodynamic venous mapping). We rando-
mized our study population Groups 2 in three Subgroup,
admit to hospital, to receive : A) 33 pts. fondaparinux
sodium, 2,5 mg/0,5 ml, B) 45 pts. enoxaparin sodium
40 mg /0,4ml, C) 111 pts. receiving other therapy.
Results
We have observed a minor incidence of venous
thrombo-embolism (DVT) in Group 1 (that receiving
for 45% LMWH and the remaining other) respectively
the total Group two, as shown in Table 1, with a signifi-
cant increase in thrombo-embolic risk, especially in the
Subgroup C (absence LMW).
Conclusions
IVC is a disease of great social impact, certainly under-
estimated by the medical profession itself, also to its
consequences. Therefore, we believe that in agreement
with the major trials (Medenox, ecc.) IVC is a disease
that strengthens the trombo-embolic risk comorbidity
in CHD.
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Table 1
N.
pts.
Aged DVT EP P<
Group 1 (CHD) 214 71+/12years 5,14 % (11case) 1
case
Group2 (CHD/
IVC)
187 76+/-9
years
8,5 % (16 case) 1
case
0,01
Subgroup A 33 72+/-4
years
3 % (1 case)
Subgroup B 45 74+/-6
years
2,2 % (1 case)
Subgroup C 111 75+/-9
years
12,6 % (14
case)
1
case
0,01
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